{"id":"https://openalex.org/W2103244604","doi":"https://doi.org/10.1128/jcm.42.10.4744-4748.2004","title":"Detection of Galactomannan Antigenemia in Patients Receiving Piperacillin-Tazobactam and Correlations between In Vitro, In Vivo, and Clinical Properties of the Drug-Antigen Interaction","display_name":"Detection of Galactomannan Antigenemia in Patients Receiving Piperacillin-Tazobactam and Correlations between In Vitro, In Vivo, and Clinical Properties of the Drug-Antigen Interaction","alternate_titles":[],"publication_year":2004,"publication_date":"2004-10-01","ids":{"openalex":"https://openalex.org/W2103244604","doi":"https://doi.org/10.1128/jcm.42.10.4744-4748.2004","mag":"2103244604","pmid":"https://pubmed.ncbi.nlm.nih.gov/15472335","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/522332"},"language":"en","primary_location":{"id":"doi:10.1128/jcm.42.10.4744-4748.2004","doi":"https://doi.org/10.1128/jcm.42.10.4744-4748.2004","is_oa":false,"landing_page_url":"https://doi.org/10.1128/jcm.42.10.4744-4748.2004","pdf_url":null,"source":{"id":"https://openalex.org/S53087977","display_name":"Journal of Clinical Microbiology","issn_l":"0095-1137","issn":["0095-1137","1070-633X","1098-660X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Microbiology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2103244604"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://europepmc.org/pmc/articles/PMC522332","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071800632","display_name":"Thomas J. Walsh","orcid":"https://orcid.org/0000-0002-4142-8711","observed_orcids":["https://orcid.org/0000-0002-4142-8711"]},"institutions":[{"id":"https://openalex.org/I4210123359","display_name":"National Cancer Institute","ror":"https://ror.org/02t771148","country_code":"UA","type":"facility","lineage":["https://openalex.org/I4210123359"]},{"id":"https://openalex.org/I4210134348","display_name":"National Cancer Institute","ror":"https://ror.org/044ybef51","country_code":"MY","type":"government","lineage":["https://openalex.org/I105292261","https://openalex.org/I4210134348"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4387155507","display_name":"Instituto Nacional del C\u00e1ncer","ror":"https://ror.org/02vkzd588","country_code":"AR","type":"facility","lineage":["https://openalex.org/I4387155507"]}],"countries":["AR","MY","UA","US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Thomas J. Walsh","raw_affiliation_strings":["Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute","institution_ids":["https://openalex.org/I4210123359","https://openalex.org/I4210134348","https://openalex.org/I4210140884","https://openalex.org/I4387155507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035206354","display_name":"Shmuel Shoham","orcid":"https://orcid.org/0000-0001-7276-7786","observed_orcids":["https://orcid.org/0000-0001-7276-7786"]},"institutions":[{"id":"https://openalex.org/I1285739803","display_name":"MedStar Washington Hospital Center","ror":"https://ror.org/05ry42w04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285739803","https://openalex.org/I86755215"]},{"id":"https://openalex.org/I2801951336","display_name":"Washington Hospital","ror":"https://ror.org/00jerb145","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801951336"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shmuel Shoham","raw_affiliation_strings":["Division of Infectious Diseases, Washington Hospital Center, Washington, D.C"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, Washington Hospital Center, Washington, D.C","institution_ids":["https://openalex.org/I1285739803","https://openalex.org/I2801951336"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062858475","display_name":"R\u016bta Petraitien\u0117","orcid":"https://orcid.org/0000-0002-3269-8058","observed_orcids":["https://orcid.org/0000-0002-3269-8058"]},"institutions":[{"id":"https://openalex.org/I4210123359","display_name":"National Cancer Institute","ror":"https://ror.org/02t771148","country_code":"UA","type":"facility","lineage":["https://openalex.org/I4210123359"]},{"id":"https://openalex.org/I4210134348","display_name":"National Cancer Institute","ror":"https://ror.org/044ybef51","country_code":"MY","type":"government","lineage":["https://openalex.org/I105292261","https://openalex.org/I4210134348"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4387155507","display_name":"Instituto Nacional del C\u00e1ncer","ror":"https://ror.org/02vkzd588","country_code":"AR","type":"facility","lineage":["https://openalex.org/I4387155507"]}],"countries":["AR","MY","UA","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ruta Petraitiene","raw_affiliation_strings":["Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute","institution_ids":["https://openalex.org/I4210123359","https://openalex.org/I4210134348","https://openalex.org/I4210140884","https://openalex.org/I4387155507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054425270","display_name":"Tin Sein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123359","display_name":"National Cancer Institute","ror":"https://ror.org/02t771148","country_code":"UA","type":"facility","lineage":["https://openalex.org/I4210123359"]},{"id":"https://openalex.org/I4210134348","display_name":"National Cancer Institute","ror":"https://ror.org/044ybef51","country_code":"MY","type":"government","lineage":["https://openalex.org/I105292261","https://openalex.org/I4210134348"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4387155507","display_name":"Instituto Nacional del C\u00e1ncer","ror":"https://ror.org/02vkzd588","country_code":"AR","type":"facility","lineage":["https://openalex.org/I4387155507"]}],"countries":["AR","MY","UA","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tin Sein","raw_affiliation_strings":["Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute","institution_ids":["https://openalex.org/I4210123359","https://openalex.org/I4210134348","https://openalex.org/I4210140884","https://openalex.org/I4387155507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040164919","display_name":"Robert L. Schaufele","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123359","display_name":"National Cancer Institute","ror":"https://ror.org/02t771148","country_code":"UA","type":"facility","lineage":["https://openalex.org/I4210123359"]},{"id":"https://openalex.org/I4210134348","display_name":"National Cancer Institute","ror":"https://ror.org/044ybef51","country_code":"MY","type":"government","lineage":["https://openalex.org/I105292261","https://openalex.org/I4210134348"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4387155507","display_name":"Instituto Nacional del C\u00e1ncer","ror":"https://ror.org/02vkzd588","country_code":"AR","type":"facility","lineage":["https://openalex.org/I4387155507"]}],"countries":["AR","MY","UA","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert Schaufele","raw_affiliation_strings":["Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute","institution_ids":["https://openalex.org/I4210123359","https://openalex.org/I4210134348","https://openalex.org/I4210140884","https://openalex.org/I4387155507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037778529","display_name":"Amy M. Kelaher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123359","display_name":"National Cancer Institute","ror":"https://ror.org/02t771148","country_code":"UA","type":"facility","lineage":["https://openalex.org/I4210123359"]},{"id":"https://openalex.org/I4210134348","display_name":"National Cancer Institute","ror":"https://ror.org/044ybef51","country_code":"MY","type":"government","lineage":["https://openalex.org/I105292261","https://openalex.org/I4210134348"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4387155507","display_name":"Instituto Nacional del C\u00e1ncer","ror":"https://ror.org/02vkzd588","country_code":"AR","type":"facility","lineage":["https://openalex.org/I4387155507"]}],"countries":["AR","MY","UA","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Amy Kelaher","raw_affiliation_strings":["Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute","institution_ids":["https://openalex.org/I4210123359","https://openalex.org/I4210134348","https://openalex.org/I4210140884","https://openalex.org/I4387155507"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Heidi Murray","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123359","display_name":"National Cancer Institute","ror":"https://ror.org/02t771148","country_code":"UA","type":"facility","lineage":["https://openalex.org/I4210123359"]},{"id":"https://openalex.org/I4210134348","display_name":"National Cancer Institute","ror":"https://ror.org/044ybef51","country_code":"MY","type":"government","lineage":["https://openalex.org/I105292261","https://openalex.org/I4210134348"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4387155507","display_name":"Instituto Nacional del C\u00e1ncer","ror":"https://ror.org/02vkzd588","country_code":"AR","type":"facility","lineage":["https://openalex.org/I4387155507"]}],"countries":["AR","MY","UA","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Heidi Murray","raw_affiliation_strings":["Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute","institution_ids":["https://openalex.org/I4210123359","https://openalex.org/I4210134348","https://openalex.org/I4210140884","https://openalex.org/I4387155507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048838258","display_name":"Christine Mya-San","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123359","display_name":"National Cancer Institute","ror":"https://ror.org/02t771148","country_code":"UA","type":"facility","lineage":["https://openalex.org/I4210123359"]},{"id":"https://openalex.org/I4210134348","display_name":"National Cancer Institute","ror":"https://ror.org/044ybef51","country_code":"MY","type":"government","lineage":["https://openalex.org/I105292261","https://openalex.org/I4210134348"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4387155507","display_name":"Instituto Nacional del C\u00e1ncer","ror":"https://ror.org/02vkzd588","country_code":"AR","type":"facility","lineage":["https://openalex.org/I4387155507"]}],"countries":["AR","MY","UA","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christine Mya-San","raw_affiliation_strings":["Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute","institution_ids":["https://openalex.org/I4210123359","https://openalex.org/I4210134348","https://openalex.org/I4210140884","https://openalex.org/I4387155507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109136757","display_name":"John D Bacher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210127607","display_name":"Office of Research Services","ror":"https://ror.org/02yrzyf97","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210091794","https://openalex.org/I4210127607"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John Bacher","raw_affiliation_strings":["Surgery Service, Veterinary Resources Program, Office of Research Services, National Institutes of Health, Bethesda"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Surgery Service, Veterinary Resources Program, Office of Research Services, National Institutes of Health, Bethesda","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210127607"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073959865","display_name":"Vidmantas Petraitis","orcid":"https://orcid.org/0000-0001-6811-4467","observed_orcids":["https://orcid.org/0000-0001-6811-4467"]},"institutions":[{"id":"https://openalex.org/I4210123359","display_name":"National Cancer Institute","ror":"https://ror.org/02t771148","country_code":"UA","type":"facility","lineage":["https://openalex.org/I4210123359"]},{"id":"https://openalex.org/I4210134348","display_name":"National Cancer Institute","ror":"https://ror.org/044ybef51","country_code":"MY","type":"government","lineage":["https://openalex.org/I105292261","https://openalex.org/I4210134348"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4387155507","display_name":"Instituto Nacional del C\u00e1ncer","ror":"https://ror.org/02vkzd588","country_code":"AR","type":"facility","lineage":["https://openalex.org/I4387155507"]},{"id":"https://openalex.org/I880747138","display_name":"Science Applications International Corporation (United States)","ror":"https://ror.org/00zv91802","country_code":"US","type":"company","lineage":["https://openalex.org/I880747138"]}],"countries":["AR","MY","UA","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Vidmantas Petraitis","raw_affiliation_strings":["Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute","SAIC, Frederick, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute","institution_ids":["https://openalex.org/I4210123359","https://openalex.org/I4210134348","https://openalex.org/I4210140884","https://openalex.org/I4387155507"]},{"raw_affiliation_string":"SAIC, Frederick, Maryland","institution_ids":["https://openalex.org/I880747138"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5071800632"],"corresponding_institution_ids":["https://openalex.org/I4210123359","https://openalex.org/I4210134348","https://openalex.org/I4210140884","https://openalex.org/I4387155507"],"apc_list":null,"apc_paid":null,"fwci":9.441,"has_fulltext":false,"cited_by_count":168,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.98564027,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"42","issue":"10","first_page":"4744","last_page":"4748"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/piperacillin-tazobactam","display_name":"piperacillin-tazobactam","score":0.9710000157356262},{"id":"https://openalex.org/keywords/invasive-aspergillosis","display_name":"invasive aspergillosis","score":0.8289999961853027},{"id":"https://openalex.org/keywords/immunocompromised-patients","display_name":"immunocompromised patients","score":0.7919999957084656},{"id":"https://openalex.org/keywords/rabbit-pharmacokinetics","display_name":"rabbit pharmacokinetics","score":0.6010000109672546}],"concepts":[{"id":"https://openalex.org/C2780782397","wikidata":"https://www.wikidata.org/wiki/Q421603","display_name":"Galactomannan","level":3,"score":0.9468561410903931},{"id":"https://openalex.org/C2778193466","wikidata":"https://www.wikidata.org/wiki/Q423787","display_name":"Piperacillin","level":4,"score":0.8317921161651611},{"id":"https://openalex.org/C2778266534","wikidata":"https://www.wikidata.org/wiki/Q423376","display_name":"Tazobactam","level":5,"score":0.7418073415756226},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6462291479110718},{"id":"https://openalex.org/C2777858937","wikidata":"https://www.wikidata.org/wiki/Q423376","display_name":"Piperacillin/tazobactam","level":5,"score":0.6340696811676025},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5605258941650391},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.515528678894043},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45947426557540894},{"id":"https://openalex.org/C2776391196","wikidata":"https://www.wikidata.org/wiki/Q259626","display_name":"Aspergillosis","level":2,"score":0.43431439995765686},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4214737117290497},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.41829216480255127},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.41356921195983887},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3774030804634094},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.34919607639312744},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32927441596984863},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19970735907554626},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.10993799567222595},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.10644766688346863},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.09346741437911987},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C2779631663","wikidata":"https://www.wikidata.org/wiki/Q425152","display_name":"Imipenem","level":4,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077725","descriptor_name":"Piperacillin, Tazobactam Drug Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000946","descriptor_name":"Antigens, Fungal","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D001228","descriptor_name":"Aspergillosis","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D004797","descriptor_name":"Enzyme-Linked Immunosorbent Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005189","descriptor_name":"False Positive Reactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005690","descriptor_name":"Galactose","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008351","descriptor_name":"Mannans","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D008351","descriptor_name":"Mannans","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D010397","descriptor_name":"Penicillanic Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010397","descriptor_name":"Penicillanic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D010397","descriptor_name":"Penicillanic Acid","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D010878","descriptor_name":"Piperacillin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010878","descriptor_name":"Piperacillin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1128/jcm.42.10.4744-4748.2004","doi":"https://doi.org/10.1128/jcm.42.10.4744-4748.2004","is_oa":false,"landing_page_url":"https://doi.org/10.1128/jcm.42.10.4744-4748.2004","pdf_url":null,"source":{"id":"https://openalex.org/S53087977","display_name":"Journal of Clinical Microbiology","issn_l":"0095-1137","issn":["0095-1137","1070-633X","1098-660X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Microbiology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:142117","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC522332","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:522332","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC522332/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Clin Microbiol","raw_type":"Text"},{"id":"pmid:15472335","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15472335","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical microbiology","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.598.6818","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.598.6818","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"https://dl.dropboxusercontent.com/u/35589116/15243943.pdf","raw_type":"text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:142117","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC522332","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1915036617","https://openalex.org/W1969650434","https://openalex.org/W1985985205","https://openalex.org/W1997330385","https://openalex.org/W2044257947","https://openalex.org/W2052449428","https://openalex.org/W2053261047","https://openalex.org/W2091637502","https://openalex.org/W2103074783","https://openalex.org/W2108781643","https://openalex.org/W2114580519","https://openalex.org/W2120388340","https://openalex.org/W2123454450","https://openalex.org/W2124899474","https://openalex.org/W2128039798","https://openalex.org/W2167506258","https://openalex.org/W2266208874","https://openalex.org/W2955504961","https://openalex.org/W4300904188"],"related_works":["https://openalex.org/W2463293401","https://openalex.org/W2138585943","https://openalex.org/W2079157140","https://openalex.org/W2898765022","https://openalex.org/W2122080085","https://openalex.org/W2152758627","https://openalex.org/W2037129801","https://openalex.org/W2105225883","https://openalex.org/W2048376344","https://openalex.org/W2035542986"],"abstract_inverted_index":{"Recent":[0],"case":[1],"reports":[2],"describe":[3],"patients":[4,182,224,251,330],"receiving":[5,191,210,228,252,266,310,331],"piperacillin-tazobactam":[6,36,75,93,140,211,253,298,311],"who":[7,189],"were":[8,190,199],"found":[9],"to":[10,25,116,125,128,150,223,236,261,273,318],"have":[11],"circulating":[12,148,204,312,336],"galactomannan":[13,38,82,98,149,303,313,337],"detected":[14],"by":[15,122,172,346],"the":[16,26,46,58,96,166,173,339,347],"double":[17,350],"sandwich":[18,351],"enzyme-linked":[19],"immunosorbent":[20],"assay":[21],"(ELISA)":[22],"system,":[23],"leading":[24],"false":[27],"presumption":[28],"of":[29,35,54,65,81,92,114,120,132,139,147,155,160,176,178,186,203,249,263,275,302],"invasive":[30,187,344],"aspergillosis.":[31],"Since":[32],"this":[33,55,332],"property":[34],"and":[37,51,157,193,234,272,321,324],"ELISA":[39],"is":[40],"not":[41,328],"well":[42],"understood,":[43],"we":[44],"investigated":[45],"in":[47,49,72,84,101,145,294,305,308,316],"vitro,":[48,306],"vivo,":[50],"clinical":[52],"properties":[53],"interaction.":[56],"Among":[57],"12":[59],"reconstituted":[60],"antibiotics":[61,192,230,268,289],"representing":[62],"four":[63],"classes":[64],"antibacterial":[66],"compounds":[67],"that":[68,165,287,290,307,325],"are":[69,291],"commonly":[70,292],"used":[71,293],"immunocompromised":[73,295],"patients,":[74,296],"expressed":[76],"a":[77,109,117,129,151,158,169],"distinctively":[78],"high":[79],"level":[80],"antigen":[83,167,304,314],"vitro":[85],"(P":[86,105,244,269,281],"=":[87,106,208,226,270,282],"0.001).":[88,246],"After":[89],"intravenous":[90],"infusion":[91],"into":[94],"rabbits,":[95],"serum":[97,216,255],"index":[99],"(GMI)":[100],"vivo":[102,317],"changed":[103],"significantly":[104,213,319],"0.0007)":[107],"from":[108],"preinfusion":[110],"mean":[111,118,130,152,215],"baseline":[112],"value":[113],"0.27":[115],"GMI":[119,131,154,217,256],"0.83":[121],"30":[123],"min":[124],"slowly":[126],"decline":[127],"0.44":[133],"24":[134],"h":[135],"later.":[136],"Repeated":[137],"administration":[138,177],"over":[141],"7":[142],"days":[143],"resulted":[144],"accumulation":[146],"peak":[153],"1.31":[156],"nadir":[159],"0.53.":[161],"Further":[162],"studies":[163],"revealed":[164],"reached":[168],"steady":[170],"state":[171],"third":[174],"day":[175],"piperacillin-tazobactam.":[179],"Twenty-six":[180],"hospitalized":[181],"with":[183],"no":[184],"evidence":[185],"aspergillosis":[188,345],"ten":[194,276],"healthy":[195,237,277],"blood":[196,238,278],"bank":[197,239,279],"donors":[198,240,280],"studied":[200],"for":[201,343],"expression":[202],"galactomannan.":[205],"Patients":[206],"(n":[207,225],"13)":[209,227],"had":[212,254],"greater":[214],"values":[218,257],"(0.74":[219],"+/-":[220,232,242],"0.14)":[221],"compared":[222,235,260],"other":[229,267],"(0.14":[231,241],"0.08)":[233],"0.06)":[243],"<":[245],"Five":[247],"(38.5%)":[248],"thirteen":[250,264],">":[258],"0.5":[259],"none":[262,274],"subjects":[265],"0.039)":[271],"0.046).":[283],"These":[284],"data":[285],"demonstrate":[286,335],"among":[288],"only":[297],"contains":[299],"significant":[300],"amounts":[301],"animals":[309],"accumulates":[315],"increased":[320],"sustained":[322],"levels,":[323],"some":[326],"but":[327],"all":[329],"antibiotic":[333],"will":[334],"above":[338],"threshold":[340],"considered":[341],"positive":[342],"recently":[348],"licensed":[349],"ELISA.":[352]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2103244604","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
